Cardiology Conference-CVC 2026

The technology behind pacemakers has rapidly advanced in recent years, offering new and exciting opportunities for patients with cardiac arrhythmias and conduction disorders. Today's pacemakers not only restore normal heart rhythm, which can significantly improve quality of life, but they are also associated with lower complication rates than traditional pacemakers. One of the major developments has been the creation of leadless pacemakers, which are miniaturized devices that are implanted directly into the heart without the need for conventional leads, and therefore may eliminate some of the risks involved with conventional leads—risk of lead dislodgement, infection, or complications of the procedural nature—and their use is gaining popularity in cardiology.

Biventricular pacemakers (from cardiac resynchronization therapy: CRT) are aimed at patients with heart failure and ventricular dyssynchrony by improving cardiac efficiency, exercise tolerance, and survival. MRI-compatible pacemakers improve the ability to obtain MRIs and other diagnostic studies without impacting the functionality of the pacemaker, and remote monitoring and wireless connectivity offer the potential for continuous tracking of device performance and patient status allowing for timely intervention in cases of arrhythmia or device-related concerns. These advances in pacemaker technology collectively have provided undeniable benefit with relief of symptoms, prevention of bradycardia-related complications, and decreasing hospitalization and improving long-term outcomes. The future of pacemaker development will undoubtedly focus on smaller, longer-lasting devices linked to wearable technology and advances in AI and adaptive pacing in response to changing physiology and patient activity levels. Overall, the advancements in pacing therapy have improved its safety, efficacy, and breadth of indications.